US2005059674A1PendingUtilityA1

Method of treating middle ear infections

59
Priority: Sep 21, 2001Filed: Sep 22, 2004Published: Mar 17, 2005
Est. expirySep 21, 2021(expired)· nominal 20-yr term from priority
Inventors:G. Michael WallPeter J. Conroy
A61P 43/00A61K 47/12A61P 31/04A61K 31/495A61K 31/545A61K 47/38A61K 9/0046A61K 31/56A61K 31/573A61K 31/57A61P 27/16A61K 47/02A61K 9/10A61K 31/496A61P 31/00A61K 47/32
59
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Aqueous suspension formulations containing dexamethasone and ciprofloxacin are disclosed for the treatment of middle ear infections in human patients having an open tympanic membrane.

Claims

exact text as granted — not AI-modified
1 - 11 . (cancelled).  
     
     
         12 . A method of reducing granulation tissue associated with a middle ear infection in a human patient diagnosed as having otitis media and an open tympanic membrane in at least one ear comprising the steps of: 
 (a) topically applying into the ear canal of the patient's ear an aqueous suspension composition containing a combination of ciprofloxacin and dexamethasone.

Join the waitlist — get patent alerts

Track US2005059674A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.